GlassScriptPhysician profile
David Alan Hornback
NPI 1790770964
$951.16
in general payments reported to CMS, 2019-2025
13 companies · $39.38 in 2025
The $39.38 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $84.99 · 2021: $37.40 · 2022: $288 · 2023: $32.67 · 2024: $108 · 2025: $39.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.15 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.15 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $341.08 | 2019-2024 | |
| Genzyme Corporation | $238.40 | 2019 | |
| Janssen Biotech, INC. | $91.66 | 2022 | |
| Clovis Oncology, INC. | $84.99 | 2020 | |
| Blue Earth Diagnostics | $37.40 | 2021 | |
| Boston Scientific Corporation | $36.47 | 2023-2025 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $23.10 | 2024 | |
| Siemens Medical Solutions USA, INC. | $21.58 | 2025 | Eclipse Treatment Planning System For External Beam Radiation Therapy, Varian Ethos Treatment Planning |
| Palette Life Sciences, INC. | $18.73 | 2022 | |
| Myriad Genetic Laboratories, INC. | $17.59 | 2022 | |
| Mirati Therapeutics, INC. | $14.00 | 2023 | Krazati |
| Bayer Healthcare Pharmaceuticals INC. | $13.76 | 2019 | |
| Varian Medical Systems, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hornback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.